Loading…
Alzamend Neuro, Inc. is projected to decline to $1.03 by 2027, a -11% move from its current price of $1.15. ALZN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.10 | $1.15 | $1.20 | +0.01% |
| May 30 | $1.08 | $1.15 | $1.23 | +0.01% |
| May 31 | $1.06 | $1.15 | $1.25 | +0.02% |
| Jun 1 | $1.05 | $1.15 | $1.26 | +0.02% |
| Jun 2 | $1.04 | $1.15 | $1.28 | +0.03% |
| Jun 3 | $1.03 | $1.15 | $1.29 | +0.04% |
| Jun 4 | $1.02 | $1.15 | $1.30 | +0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.02 | $1.15 | $1.30 | +0.04% |
| Week 2 | $0.9677 | $1.15 | $1.37 | +0.08% |
| Week 3 | $0.9311 | $1.15 | $1.42 | +0.13% |
| Week 4 | $0.9014 | $1.15 | $1.47 | +0.17% |
| Week 5 | $0.876 | $1.15 | $1.52 | +0.21% |
| Week 6 | $0.8537 | $1.15 | $1.56 | +0.25% |
| Week 7 | $0.8338 | $1.15 | $1.60 | +0.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient\'s immunological system to combat Alzheimer\'s disease.
Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Alzamend Neuro, Inc. (ALZN) sits in the Healthcare sector. The shares trade at a current price of $1.13 and a market capitalization of $4.3M, with a ranking of 5381.
The stock trades in a micro-cap category, reflecting a small market footprint despite its clinical-stage focus.
Forecasts show a varied price path, with 2026 averaging $1.13, and later years showing significant upside by 2050, where the average price is projected at $3.29 and the max at $7.57, indicating higher upside potential compared with earlier years.
A major floor 25.4% below — a decisive break under it would weaken the trend.
The nearest floor, 13.0% below — buyers have tended to step in here.
The nearest ceiling, 4.3% above — a clean break opens room to run.
A major ceiling 111.3% above — clearing it would confirm fresh momentum.
Key ALZN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALZN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.16 | Sell | $1.14 | Buy |
| MA 10 | $1.09 | Buy | $1.11 | Buy |
| MA 20 | $1.09 | Buy | $1.10 | Buy |
| MA 50 | $1.18 | Sell | $1.24 | Sell |
| MA 100 | $1.63 | Sell | $1.55 | Sell |
| MA 200 | $1.97 | Sell | $3.98 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.82 | Neutral |
| Stoch RSI (14) | 74.56 | Neutral |
| CCI (20) | 86.02 | Neutral |
| Williams %R (14) | -26.32 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 7.48 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 73.68 | Neutral |
| TRIX (15) | -0.41 | Sell |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 65.60 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 1.18 | Sell |
| ADX (14) | 17.09 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is NEUTRAL with RSI(14) at 50.
The 50-day simple moving average sits at $1.21 and the 200-day at $1.98, framing near-term momentum and resistance around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.858 | $1.15 | $1.61 | 0% | Neutral | |
| $0.7597 | $1.03 | $1.50 | -11% | Neutral | |
| $0.7288 | $1.04 | $1.60 | -10% | Neutral | |
| $0.6072 | $0.9009 | $1.45 | -22% | Bearish | |
| $0.6977 | $1.08 | $1.79 | -6% | Neutral | |
| $0.9259 | $1.48 | $2.54 | +29% | Bullish | |
| $0.7803 | $1.29 | $2.28 | +12% | Neutral | |
| $0.7207 | $1.23 | $2.23 | +7% | Neutral | |
| $0.7407 | $1.31 | $2.42 | +14% | Neutral | |
| $0.6234 | $1.13 | $2.14 | -1% | Neutral | |
| $0.7307 | $1.54 | $3.17 | +34% | Bullish | |
| $1.51 | $3.36 | $7.73 | +192% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.858 | $1.15 | $1.35 | +0.00% |
| June 2026 | $0.9375 | $1.12 | $1.38 | -2.79% |
| July 2026 | $0.9557 | $1.16 | $1.46 | +3.43% |
| August 2026 | $0.9303 | $1.14 | $1.46 | -1.54% |
| September 2026 | $0.8879 | $1.10 | $1.42 | -3.65% |
| October 2026 | $0.92 | $1.15 | $1.51 | +4.53% |
| November 2026 | $0.9658 | $1.21 | $1.61 | +5.80% |
| December 2026 | $0.9468 | $1.20 | $1.61 | -1.24% |
Click any year to see its month-by-month ALZN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ALZN is projected to trade between $0.858 and $1.61, averaging $1.15 — a potential gain of 0% from today's $1.15. Price action looks broadly range-bound.
Alzamend Neuro, Inc.'s 2027 outlook centres on $1.03, within a $0.7597 to $1.50 range. That is -11% versus the projected 2026 average. That marks a -11% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, ALZN could reach as high as $1.60, with a base case around $1.04 and support toward $0.7288 — roughly -10% from $1.15. Price action looks broadly range-bound.
Expect ALZN to range from $0.6072 to $1.45 through 2029. The $0.9009 average target implies a -22% move from current prices. That is -13% versus the projected 2028 average. Expect choppier, lower action through this leg of the cycle.
The ALZN price prediction for 2030 points to an average of $1.08 (low $0.6977, high $1.79) — a potential decline of -6% on today's $1.15. Price action looks broadly range-bound.
In 2031, ALZN is projected to trade between $0.9259 and $2.54, averaging $1.48 — a potential gain of +29% from today's $1.15. That is up +38% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Alzamend Neuro, Inc.'s 2032 outlook centres on $1.29, within a $0.7803 to $2.28 range. That is -13% versus the projected 2031 average. That marks a +12% change versus current levels. Price action looks broadly range-bound.
By 2033, ALZN could reach as high as $2.23, with a base case around $1.23 and support toward $0.7207 — roughly +7% from $1.15. A consolidation phase looks the most probable path here.
Expect ALZN to range from $0.7407 to $2.42 through 2034. The $1.31 average target implies a +14% move from current prices. That is up +6% on the projected 2033 average. Price action looks broadly range-bound.
The ALZN price prediction for 2035 points to an average of $1.13 (low $0.6234, high $2.14) — a potential decline of -1% on today's $1.15. A consolidation phase looks the most probable path here.
In 2040, ALZN is projected to trade between $0.7307 and $3.17, averaging $1.54 — a potential gain of +34% from today's $1.15. That is up +36% on the projected 2035 average. Momentum favours further upside here.
Alzamend Neuro, Inc.'s 2050 outlook centres on $3.36, within a $1.51 to $7.73 range. That is up +118% on the projected 2040 average. That marks a +192% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALZN today (≈ 869.565217 ALZN) could be worth
$2,921.1
+$1,921.1 (+192%) by 2050 · US Dollar
Based on the average projected ALZN price of $3.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALZNwould be worth at today's price.
$1,000 invested in ALZN on May 27, 2025 (≈ 289.855068 ALZN) would be worth
$333.33
-$666.67 (-66.7%) today · 0.33× · US Dollar
Based on a ALZN entry price of $3.45 vs. today's $1.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.2 | $958.33 | -4.2% |
| 1 month ago | $1.08 | $1,064.81 | +6.5% |
| 3 months ago | $2.08 | $552.88 | -44.7% |
| 6 months ago | $2.19 | $525.11 | -47.5% |
| 1 year ago | $3.45 | $333.33 | -66.7% |
| All time (5.0y) ago | $18,225 | $0.06 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALZN forecast.
Our base-case forecast reaches $2.30 around 2050.
Implied market cap at $2.30: $8.75M
The multi-year forecast shows a dip through 2029, with 2026 average $1.13, 2027 average $1.01 (-10.9%), 2028 average $1.00 (-11.1%), and 2029 average $0.864 (-23.5%), with sentiment largely NEUTRAL in those years. The forecast then turns higher starting in 2030, with 2030 average $1.06 (-6%), 2031 average $1.46 (29.4%), followed by 2032 average $1.25 (10.8%), 2033 average $1.21 (7%), and 2034 average $1.28 (13.3%). 2035 is projected at $1.08 (-4.4%).
By 2040 the forecast shows min $0.6729, avg $1.49, max $3.14; ROI 31.5%; sentiment BULLISH. By 2050 the forecast shows min $1.48, avg $3.29, max $7.57; ROI 191.3%; sentiment BULLISH.
These are estimates, not guarantees, and reflect upside potential but also risk given early declines and high volatility.
Tap a question to reveal the answer.
Min $0.6748, Avg $1.06, Max $1.80; ROI -6; Sentiment NEUTRAL.
Forecasts show mixed performance with near-term declines (2027-2029) and later bullish years (2031, 2040, 2050). 2031 avg $1.46 ROI 29.4%; 2040 avg $1.49 ROI 31.5%; 2050 avg $3.29 ROI 191.3%. These are estimates, not guarantees.
Yes. The 2050 max forecast is $7.57 with an average of $3.29 and ROI of 191.3%. Sentiment BULLISH.
Min $0.858, Avg $1.13, Max $1.59; ROI 0; Sentiment NEUTRAL.
Min $0.6729, Avg $1.49, Max $3.14; ROI 31.5; Sentiment BULLISH.
Alzamend Neuro, Inc. Community Discussion
0Share your Alzamend Neuro, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.